CLOZAPINE FOR THE CONTROL OF HEMIBALLISMUS

被引:21
作者
BASHIR, K [1 ]
MANYAM, BV [1 ]
机构
[1] SO ILLINOIS UNIV, SCH MED, DEPT NEUROL, SPRINGFIELD, IL 62794 USA
关键词
HEMIBALLISMUS; CLOZAPINE;
D O I
10.1097/00002826-199410000-00012
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Pharmacological agents used for the control of ballistic movements include chloral hydrate, barbiturates, paraldehyde, bromides, phenothiazines, progabide, haloperidol, pimozide, reserpine, tetrabenazine, sodium valproate, and dimethylaminoethanol. These agents are believed to act by different mechanisms, including modification of dopaminergic, GABAergic, or cholinergic mechanisms. We report a case where, after failure of haloperidol, phenobarbital, and pimozide, the hemiballistic movements were controlled with clozapine.
引用
收藏
页码:477 / 480
页数:4
相关论文
共 26 条
[1]   DIFFERENTIAL-EFFECTS OF D1 AND D2 AGONISTS IN MPTP-TREATED PRIMATES - FUNCTIONAL IMPLICATIONS FOR PARKINSONS-DISEASE [J].
BOYCE, S ;
RUPNIAK, NMJ ;
STEVENTON, MJ ;
IVERSEN, SD .
NEUROLOGY, 1990, 40 (06) :927-933
[2]  
BUNNEY BS, 1992, BR J PSYCHIATRY S, V17
[3]   GENERAL PHARMACOLOGY OF CLOZAPINE [J].
COWARD, DM .
BRITISH JOURNAL OF PSYCHIATRY, 1992, 160 :5-11
[4]   EXPERIMENTAL HEMICHOREA HEMIBALLISMUS IN THE MONKEY - STUDIES ON THE INTRACEREBRAL SITE OF ACTION IN A DRUG-INDUCED DYSKINESIA [J].
CROSSMAN, AR ;
SAMBROOK, MA ;
JACKSON, A .
BRAIN, 1984, 107 (JUN) :579-596
[5]   HEMIBALLISM-HEMICHOREA - CLINICAL AND PHARMACOLOGIC FINDINGS IN 21 PATIENTS [J].
DEWEY, RB ;
JANKOVIC, J .
ARCHIVES OF NEUROLOGY, 1989, 46 (08) :862-867
[6]   CLOZAPINE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES, AND THERAPEUTIC USE IN SCHIZOPHRENIA [J].
FITTON, A ;
HEEL, RC .
DRUGS, 1990, 40 (05) :727-747
[7]   CLOZAPINE AND D1/D2 ANTAGONISM IN EXTRAPYRAMIDAL FUNCTIONS [J].
GERLACH, J ;
HANSEN, L .
BRITISH JOURNAL OF PSYCHIATRY, 1992, 160 :34-37
[8]  
GOMEZMANCILLA B, 1991, J PHARMACOL EXP THER, V259, P409
[9]  
JANN MW, 1991, PHARMACOTHERAPY, V11, P179
[10]   PHARMACOKINETICS AND PHARMACODYNAMICS OF CLOZAPINE [J].
JANN, MW ;
GRIMSLEY, SR ;
GRAY, EC ;
CHANG, WH .
CLINICAL PHARMACOKINETICS, 1993, 24 (02) :161-176